Collegium Pharmaceutical, Inc. (COLL)
47.03
-0.88
(-1.84%)
USD |
NASDAQ |
Dec 09, 16:00
48.39
+1.36
(+2.89%)
After-Hours: 06:50
Collegium Pharmaceutical Market Cap: 1.487B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.772B |
| Alnylam Pharmaceuticals, Inc. | 54.85B |
| Altimmune, Inc. | 575.97M |
| Vertex Pharmaceuticals, Inc. | 110.88B |
| Viking Therapeutics, Inc. | 4.214B |
Market Cap Related Metrics
| PE Ratio | 29.27 |
| PS Ratio | 2.352 |
| Price to Book Value | 5.410 |
| Price to Free Cash Flow | 6.156 |
| Price | 47.03 |
| Earnings Yield | 3.42% |
| Operating PE Ratio | 10.96 |
| Normalized PE Ratio | 27.48 |